The Three-dimensional Structures of Antagonistic and Agonistic Forms of the Glucocorticoid Receptor Ligand-binding Domain-Reference-Cited by-同舟云学术

The Three-dimensional Structures of Antagonistic and Agonistic Forms of the Glucocorticoid Receptor Ligand-binding Domain

Published:2003-06 Issue:25 Volume:278 Page:22748-22754
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Kauppi Björn,Jakob Clarissa,Färnegårdh Mathias,Yang Jie,Ahola Harri,Alarcon Maria,Calles Karin,Engström Owe,Harlan John,Muchmore Steven,Ramqvist Anna-Karin,Thorell Susanne,Öhman Lars,Greer Jonathan,Gustafsson Jan-Åke,Carlstedt-Duke Jan,Carlquist Mats

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference43 articles.

1. Separation of the hormone- and DNA-binding sites of the hepatic glucocorticoid receptor by means of proteolysis.

2. Immunochemical analysis of the glucocorticoid receptor: identification of a third domain separate from the steroid-binding and DNA-binding domains.

3. Purified glucocorticoid receptors bind selectively in vitro to a cloned DNA fragment whose transcription is regulated by glucocorticoids in vivo.

4. Multiple specific binding sites for purified glucocorticoid receptors on mammary tumor virus DNA

5. Characterization of a steroid hormone receptor gene and mRNA in wild-type and mutant cells

Cited by 317 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protective effect of sulforaphane against depressive behavior in mice through glucocorticoid receptor antagonism;Food Bioscience;2024-10

2. Chemical space exploration with Molpher: Generating and assessing a glucocorticoid receptor ligand library;Molecular Informatics;2024-07-09

3. Neuroprotective efficacy of the glucocorticoid receptor modulator PT150 in the rotenone mouse model of Parkinson’s disease;NeuroToxicology;2024-07

4. Neuroprotective Efficacy of the Glucocorticoid Receptor Modulator PT150 in the Rotenone Mouse Model of Parkinson’s Disease;2024-04-15

5. Drug development and potential targets for Cushing's syndrome;European Journal of Medicinal Chemistry;2024-04